1. ALLA AKTIER
  2. NYHETER
  3. BOULE DIAGNOSTICS

Boule Diagnostics

Nyheter Boule Diagnostics Nyheter alla bolag
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Bulletin from the Extraordinary General Meeting August 31, 2026 in Boule Diagnostics

MARKN.

The Extraordinary General Meeting (the “EGM”) resolved to approve a loan from one of the company’s major shareholders, AB Grenspecialisten, in accordance with the Board of Directors’ proposal.

Complete proposals regarding the resolution of the EGM as set out above are available on Boule’s website, www.boule.com.

Contacts

Johan Folkunger, VD, johan.folkunger@boule.com, phone +46 (0) 70-250 54 74

Michael af Winklerfelt, CFO, michael.af.winklerfelt@boule.com, phone +46 (0)70-553 54 22

About Us
Boule Diagnostics AB (publ) is a global company consisting of two business segments, Diagnostics and OEM CDS. Diagnostics is specialized in near-patient, decentralized diagnostic solutions for human and veterinary applications, serving hospitals, clinics, laboratories. OEM CDS develops and delivers reliable reagent, blood controls and calibrators tailored for diagnostic companies worldwide.
With operations in Sweden, the United States, Mexico, and Russia, and a global distribution network spanning more than 100 countries, Boule combines a resilient business model with strong positions in key growth markets. In 2025, Boule reported net sales of SEK 490 million and has about 200 employees worldwide. Boule has been listed on Nasdaq Stockholm since 2011. http://www.boule.com

Attachments
Bulletin from the Extraordinary General Meeting August 31, 2026 in Boule Diagnostics

Datum 2026-08-31, kl 16:30
Källa MFN
Bifogade filer
Bulletin from the Extraordinary General Meeting August 31, 2026 in Boule Diagnostics